This GCP training contains all of the attested CITI Program modules from the GCP for Clinical Trials with
Investigational Drugs and Medical Devices (U.S. FDA Focus) Version 2. This ICH E6 GCP Investigator Site
Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate
BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.